EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $971,022 | -28.7% | 61,574 | -12.1% | 0.00% | 0.0% |
| Q2 2023 | $1,361,028 | -31.5% | 70,012 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $1,986,245 | -7.1% | 70,012 | -4.2% | 0.00% | -20.0% |
| Q4 2022 | $2,137,236 | +8.6% | 73,118 | -1.9% | 0.01% | +25.0% |
| Q3 2022 | $1,968,000 | +10.7% | 74,508 | +86.2% | 0.00% | 0.0% |
| Q2 2022 | $1,777,000 | +60.2% | 40,014 | +78.5% | 0.00% | +100.0% |
| Q1 2022 | $1,109,000 | +328.2% | 22,421 | +340.1% | 0.00% | – |
| Q4 2021 | $259,000 | -25.4% | 5,094 | -21.5% | 0.00% | -100.0% |
| Q3 2021 | $347,000 | +7.4% | 6,491 | -21.5% | 0.00% | 0.0% |
| Q3 2020 | $323,000 | +3.9% | 8,264 | +27.5% | 0.00% | 0.0% |
| Q2 2020 | $311,000 | -4.3% | 6,484 | -8.1% | 0.00% | 0.0% |
| Q1 2020 | $325,000 | -55.5% | 7,055 | -42.0% | 0.00% | -50.0% |
| Q4 2019 | $731,000 | -3.8% | 12,162 | -9.5% | 0.00% | 0.0% |
| Q3 2019 | $760,000 | +21.8% | 13,436 | +19.9% | 0.00% | 0.0% |
| Q2 2019 | $624,000 | +906.5% | 11,206 | +817.8% | 0.00% | – |
| Q1 2019 | $62,000 | -99.2% | 1,221 | -99.0% | 0.00% | -100.0% |
| Q4 2018 | $8,167,000 | 0.0% | 117,802 | 0.0% | 0.03% | -3.3% |
| Q3 2018 | $8,167,000 | -3.9% | 117,802 | +4.9% | 0.03% | +3.4% |
| Q2 2018 | $8,495,000 | +383.8% | 112,279 | +236.9% | 0.03% | +314.3% |
| Q1 2018 | $1,756,000 | 0.0% | 33,326 | +1.4% | 0.01% | +16.7% |
| Q4 2017 | $1,756,000 | +9.8% | 32,866 | +22.6% | 0.01% | 0.0% |
| Q3 2017 | $1,599,000 | -5.6% | 26,818 | +25.0% | 0.01% | -14.3% |
| Q2 2017 | $1,693,000 | -9.0% | 21,461 | -4.3% | 0.01% | -12.5% |
| Q1 2017 | $1,861,000 | +331.8% | 22,435 | +313.2% | 0.01% | +300.0% |
| Q4 2016 | $431,000 | -20.0% | 5,430 | -10.7% | 0.00% | -33.3% |
| Q4 2015 | $539,000 | – | 6,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |